Shots:
- The US FDA has approved the Nexus Aortic Arch Stent Graft for the treatment of aortic arch disease
- Approval was supported by the 1yr. results from the TRIOMPHE IDE trial assessing Nexus in aortic arch disease, incl. chronic aortic dissections, in pts at high risk for open surgical repair, which showed safe & effective treatment in the ascending aorta
- The Nexus System is a bimodular device designed to replicate the anatomy of the ascending aorta & arch, featuring a low-profile 20F delivery system with a pre-shaped catheter for single-pass deployment to minimize manipulation, along with an integrated branch for improved hemodynamic performance
Ref: Businesswire | Image: Endospan | Press Release
Related News: Organogenesis Reports Trial Results on PuraPly AM for Wound Healing in Diabetic Foot Ulcers
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
